Waters and University of Delaware Announce Official Opening of Immerse Delaware Lab
May 05 2022 - 8:12AM
Business Wire
News Summary:
- Waters opens its newest innovation and research laboratory at
University of Delaware (UD) Science, Technology and Advanced
Research (STAR) campus
- Immerse™ Delaware brings together students, faculty, and Waters
scientists with industry research partners to identify and address
significant challenges facing the biopharmaceutical industry
- Lab opening milestone is part of multi-year Waters-UD research
partnership to collaborate on projects with biopharma industry
stakeholders
Waters Corporation (NYSE: WAT) and The University of Delaware
announced the grand opening of Immerse™ Delaware, a new Waters
innovation and research laboratory. As part of their multi-year
research partnership announced in October 2021, the lab opening is
the first step on a journey to collaborate with biopharma
scientists both in industry and academia to advance industrial
processes for making and characterizing biotherapeutics.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20220505005202/en/
Immerse Delaware, A Waters Innovation
& Research Lab at The University of Delaware (Photo: Business
Wire)
Located at the University of Delaware Science, Technology and
Advanced Research (STAR) campus, Immerse Delaware is a fully
functional, fit-for-purpose, bioprocess laboratory enabling a
dedicated focus on the entire manufacturing process from clone
selection to quality control (QC) of drug substances. It will give
students, faculty and industry researchers access to use and
evaluate state-of-the-art analytical technologies from Waters as
well as novel analytics, consumables and software that will enable
the next generation of biotherapeutics.
“Our mission to address some of the biggest challenges in the
development and manufacturing of biotherapeutics requires an
immense amount of work, collaboration, and diversity of thought.
Immerse Delaware will enable us to tap into an ecosystem of talent
and expertise in biological manufacturing, coupled with Waters’
experience in analytical technologies, to advance and accelerate
the delivery of high-quality medicines to patients,” said Dr. Udit
Batra, President and CEO of Waters Corporation.
“As a research institution, the University of Delaware has a
long history of advancing new discoveries and innovations that make
our world safer, healthier and more vibrant,” said UD President
Dennis Assanis. “Today, the Immerse Delaware partnership with
Waters Corp. is another exciting opportunity to extend our research
impact and continue building on our successes in educating the next
generation of leaders in the field of biopharmaceutical
manufacturing.”
Waters selected University of Delaware as a partner due to its
leadership in chemical and biological manufacturing research as
well its active support of and close proximity to the National
Institute for Innovation in Manufacturing Biopharmaceuticals
(NIIMBL), a collaborative effort amongst industry, academia, and
regulators.
Notable attendees at the lab opening included: Dennis Assanis,
PhD, President, University of Delaware; Udit Batra, PhD, President
and CEO, Waters Corporation; Chai Gadde, CEO of BioTek reMEDys;
Kelvin Lee, PhD, Director, NIIMBL and Gore Professor of
Biomolecular Engineering; Levi Thompson, PhD, Dean, College of
Engineering, University of Delaware; and Michael Flemming,
President, Delaware Biosciences.
Additional Resources
- Learn more about Immerse Delaware, a Waters Innovation &
Research Lab
- Learn more about the University of Delaware’s STAR Campus
- Connect with Waters via Twitter, Facebook and LinkedIn
About the University of Delaware (www.udel.edu)
The University of Delaware, located in Newark, Delaware, traces
its beginnings to a small private academy established in 1743.
Today, UD is a research-intensive, technologically advanced
institution offering more than 150 academic majors across nine
colleges, serving more than 23,000 undergraduate and graduate
students. The University's distinguished faculty includes
internationally renowned authors, scientists and artists. The
Carnegie Foundation for the Advancement of Teaching has classified
UD as having very high research activity—a designation accorded
fewer than 3% of U.S. colleges and universities. The University’s
Science, Technology and Advanced Research (STAR) Campus in Newark
is a growing center for innovation, blending cutting-edge research,
top-notch academics and thriving businesses in one location.
Delaware has 21 varsity sports teams that compete at the Division 1
level in the Colonial Athletic Association and the Football
Championship Subdivision.
About Waters Corporation (www.waters.com)
Waters Corporation (NYSE:WAT), a global leader in analytical
instruments and software, has pioneered chromatography, mass
spectrometry, and thermal analysis innovations serving the life,
materials, and food sciences for more than 60 years. With more than
7,800 employees worldwide, Waters operates directly in more than 35
countries, including 14 manufacturing facilities, and with products
available in more than 100 countries.
Waters and Immerse are trademarks of Waters Corporation.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220505005202/en/
Andrea Boyle Tippet Senior Director, External Relations
University of Delaware aboyle@udel.edu
Kevin Kempskie Senior Director, Public Relations Waters
Corporation pr@waters.com
Waters (NYSE:WAT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Waters (NYSE:WAT)
Historical Stock Chart
From Apr 2023 to Apr 2024